Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Cash from Financing Activities (2024 - 2025)

Connect Biopharma Holdings' Cash from Financing Activities history spans 2 years, with the latest figure at $215000.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities changed N/A year-over-year to $215000.0; the TTM value through Sep 2025 reached $484000.0, changed N/A, while the annual FY2024 figure was $227000.0, 404.44% up from the prior year.
  • Cash from Financing Activities for Q3 2025 was $215000.0 at Connect Biopharma Holdings, up from $161000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $215000.0 in Q3 2025 and bottomed at $2000.0 in Q1 2025.